Subscribe for great stories in your community!
Merck has launched a biosimilar version of Remicade, Johnson & Johnson’s blockbuster drug, writes John George for Philadelphia Business Journal.
Biosimilar products are designed…
Before we send you to this site, please subscribe to our daily newsletter.